These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 15108036

  • 1. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.
    Yamane T, Kaneko A, Mohri M.
    Int J Clin Oncol; 2004 Apr; 9(2):69-73. PubMed ID: 15108036
    [Abstract] [Full Text] [Related]

  • 2. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP.
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [Abstract] [Full Text] [Related]

  • 3. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
    Suzuki S, Yamane T, Mohri M, Kaneko A.
    Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
    Muen WJ, Kingston JE, Robertson F, Brew S, Sagoo MS, Reddy MA.
    Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
    [Abstract] [Full Text] [Related]

  • 5. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.
    Venturi C, Bracco S, Cerase A, Cioni S, Galluzzi P, Gennari P, Vallone IM, Tinturini R, Vittori C, De Francesco S, Caini M, D'Ambrosio A, Toti P, Renieri A, Hadjistilianou T.
    Acta Ophthalmol; 2013 Jun; 91(4):335-42. PubMed ID: 22268993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.
    Ong SJ, Chao AN, Wong HF, Liou KL, Kao LY.
    Jpn J Ophthalmol; 2015 Mar; 59(2):109-17. PubMed ID: 25465196
    [Abstract] [Full Text] [Related]

  • 8. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA.
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.
    Pham CT, Blanc R, Lumbroso-Le Rouic L, Pistocchi S, Bartolini B, Piotin M.
    Neuroradiology; 2012 Aug; 54(8):845-8. PubMed ID: 22089977
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective Ophthalmic Artery Infusion Chemotherapy for Advanced Intraocular Retinoblastoma: CCHMC Early Experience.
    Michaels ST, Abruzzo TA, Augsburger JJ, Corrêa ZM, Lane A, Geller JI.
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):65-9. PubMed ID: 26583615
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
    Valero García S, López Briz E, Escobar Cava P, Balaguer J, Pelufo A, Megías JE, Poveda Andrés JL.
    J Oncol Pharm Pract; 2013 Jun; 19(2):159-64. PubMed ID: 23014898
    [Abstract] [Full Text] [Related]

  • 16. Selective ophthalmic arterial injection using a balloon catheter for retinoblastoma: a seven-year clinical evaluation.
    Oguro S, Chen YN, Yamane T, Mohri M, Suzuki S.
    Jpn J Ophthalmol; 2024 Jul; 68(4):346-354. PubMed ID: 38833074
    [Abstract] [Full Text] [Related]

  • 17. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma.
    Abruzzo T, Abraham K, Karani KB, Geller JI, Vadivelu S, Racadio JM, Zhang B, Correa ZM.
    AJNR Am J Neuroradiol; 2021 Jan; 42(2):354-361. PubMed ID: 33361377
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion of melphalan.
    Hadjistilianou T, Coriolani G, Bracco S, Gennari P, Caini M, Cerase A, Galimberti D, De Francesco S, De Luca M, Mastrangelo D.
    J Pediatr Ophthalmol Strabismus; 2014 Jan; 51(1):32-8. PubMed ID: 24308859
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients.
    Schaiquevich P, Buitrago E, Taich P, Torbidoni A, Ceciliano A, Fandino A, Asprea M, Requejo F, Abramson DH, Bramuglia GF, Chantada GL.
    Invest Ophthalmol Vis Sci; 2012 Jun 28; 53(7):4205-12. PubMed ID: 22628208
    [Abstract] [Full Text] [Related]

  • 20. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
    Akyüz C, Kıratlı H, Şen H, Aydın B, Tarlan B, Varan A.
    Ophthalmologica; 2015 Jun 28; 234(4):227-32. PubMed ID: 26368674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.